Drugmaker Bristol-Myers Squibb said Monday it will work with Dutch biotechnology company uniQure to develop gene therapies for cardiovascular diseases.
The companies will focus first on a treatment for congestive heart failure. They said uniQure could get more than $2.2 billion from the deal in total, and Bristol-Myers Squibb will also take a minority stake in the company.
22:33 Allergan to pay $15 million over failing to disclose merger talks9
21:40 HP Enterprise to buy cloud software company SimpliVity12
19:08 U.S. indicts three Takata executives, fines company $1 billion in faulty air bag scandal15
12:02 Bank of America tops earnings forecast, predicts 'significant increase' in net interest income20